top of page

Selected as a recipient company for the 13th term of the Small and Medium Enterprise Infrastructure Development Organization's acceleration program "FASTAR".

  • Sep 30, 2025
  • 1 min read


Our company has been selected as a recipient of support for the 13th term of "FASTAR," an acceleration program run by the Organization for Small & Medium Enterprises and Regional Innovation, JAPAN.

Using this program as a springboard, we will strongly promote the development of angiogenesis therapy using ICS for severe lower limb ischemia.


 
 
 

Comments


Latest Articles
archive
Cellfold Co., Ltd.

© 2025 by CellFold, Inc.

bottom of page